Claims by patients across 16 different states have been consolidated into a class action lawsuit against C.R. Bard for the injuries and deaths allegedly caused by inferior vena cava (IVC) filters made by the medical device manufacturing giant.
The lawsuit covers many Bard IVC filter products, including the Recovery Filter System, G2, G2 Express, Eclipse, G2X System, Meridian, and Denali. The patient injuries reportedly linked to the device include hemorrhaging, severe and persistent pain, and perforations of the tissue, vessels and organs.
The filters are each based off the model made before – the Meridian’s design came from the Eclipse, which came from the G2, which came from the Recovery. The complaint states that all of them “were fracturing, perforating, migrating, and/or tilting in the patients in which they were implanted.”
The complaint further states, “These devices are potential ticking time bombs implanted in unsuspecting patients.”
The Recovery filter alone has been linked to at least 27 deaths and hundreds of non-fatal injuries. But despite the number of complaints, Bard allegedly started a coverup campaign, hiding vital information from doctors and patients. The company even went as far as to hire a public relations firm to combat the negative publicity.
Many IVC filters are designed to be temporary, requiring the device to be removed after it is no longer needed. The FDA recommends that temporary IVC filters be removed between 29 and 54 days.. However, in many cases, the filter migrated or perforated the vein, making the device impossible to retrieve. The risk of injury or death grows the longer the device is left in the body.
Due to the high rate of failure, Bard is now facing an avalanche of lawsuits for the injuries and deaths allegedly caused by its IVC filters.
Source: Mass Tort Nexus